scispace - formally typeset
Journal ArticleDOI

Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

Reads0
Chats0
TLDR
To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic hyperplasia, new pharmacotherapies and technologies have emerged which have impacted treatment algorithms.
About
This article is published in The Journal of Urology.The article was published on 2011-05-01. It has received 970 citations till now. The article focuses on the topics: Guideline & Lower urinary tract symptoms.

read more

Citations
More filters
Journal ArticleDOI

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline

TL;DR: This Guideline provides updated, evidence‐based recommendations regarding management of LUTS/BPH utilizing surgery and minimally invasive surgical therapies; additional statements are made regarding diagnostic and pre‐operative tests.
References
More filters
Journal ArticleDOI

Urologic diseases in america project: benign prostatic hyperplasia

TL;DR: While the number of outpatient visits for BPH increased consistently during the 1990s, there was a dramatic decrease in the use of transurethral prostatectomy, inpatient hospitalization and length of hospital stay for this condition in 2000.
Journal ArticleDOI

A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia

TL;DR: For men with moderate symptoms of benign prostatic hyperplasia, surgery is more effective than watchful waiting in reducing the rate of treatment failure and improving genitourinary symptoms.
Journal ArticleDOI

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

TL;DR: Treatment with tolterodine ER plus tamsulosin for 12 weeks provides benefit for men with moderate to severe lower urinary tract symptoms including overactive bladder, and safety and tolerability is suggested.
Journal ArticleDOI

Intraoperative floppy iris syndrome associated with tamsulosin.

TL;DR: Intraoperative floppy iris syndrome occurred in approximately 2% of a cataract surgery population and appeared to be caused by tamsulosin, a systemic sympathetic α‐1A antagonist medication that is the most frequently prescribed medication for benign prostatic hypertrophy.
Related Papers (5)